Neuronal tau pathology worsens late-phase white matter degeneration after traumatic brain injury in transgenic mice.
Axon damage
Demyelination
Neuroregeneration
Tau
Traumatic brain injury
White matter
Journal
Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
26
05
2023
accepted:
08
08
2023
revised:
08
08
2023
medline:
14
9
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
ppublish
Résumé
Traumatic brain injury (TBI) causes diffuse axonal injury which can produce chronic white matter pathology and subsequent post-traumatic neurodegeneration with poor patient outcomes. Tau modulates axon cytoskeletal functions and undergoes phosphorylation and mis-localization in neurodegenerative disorders. The effects of tau pathology on neurodegeneration after TBI are unclear. We used mice with neuronal expression of human mutant tau to examine effects of pathological tau on white matter pathology after TBI. Adult male and female hTau.P301S (Tg2541) transgenic and wild-type (Wt) mice received either moderate single TBI (s-TBI) or repetitive mild TBI (r-mTBI; once daily × 5), or sham procedures. Acutely, s-TBI produced more extensive axon damage in the corpus callosum (CC) as compared to r-mTBI. After s-TBI, significant CC thinning was present at 6 weeks and 4 months post-injury in Wt and transgenic mice, with homozygous tau expression producing additional pathology of late demyelination. In contrast, r-mTBI did not produce significant CC thinning except at the chronic time point of 4 months in homozygous mice, which exhibited significant CC atrophy (- 29.7%) with increased microgliosis. Serum neurofilament light quantification detected traumatic axonal injury at 1 day post-TBI in Wt and homozygous mice. At 4 months, high tau and neurofilament in homozygous mice implicated tau in chronic axon pathology. These findings did not have sex differences detected. Conclusions: Neuronal tau pathology differentially exacerbated CC pathology based on injury severity and chronicity. Ongoing CC atrophy from s-TBI became accompanied by late demyelination. Pathological tau significantly worsened CC atrophy during the chronic phase after r-mTBI.
Identifiants
pubmed: 37578550
doi: 10.1007/s00401-023-02622-9
pii: 10.1007/s00401-023-02622-9
pmc: PMC10499978
doi:
Substances chimiques
tau Proteins
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
585-610Informations de copyright
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
Adv Exp Med Biol. 2019;1184:69-77
pubmed: 32096029
Acta Neuropathol Commun. 2021 Jun 29;9(1):118
pubmed: 34187585
J Neurol Neurosurg Psychiatry. 1956 Aug;19(3):163-85
pubmed: 13357957
JAMA Neurol. 2019 Nov 01;76(11):1298-1308
pubmed: 31380975
Neurology. 2020 Aug 11;95(6):e623-e636
pubmed: 32641529
Exp Neurol. 2023 Jan;359:114241
pubmed: 36240881
J Neurosurg. 2022 Jul 15;138(2):454-464
pubmed: 35901687
J Neuropathol Exp Neurol. 2011 Feb;70(2):157-65
pubmed: 21343885
JAMA Neurol. 2017 Dec 1;74(12):1464-1472
pubmed: 29059326
Curr Opin Neurobiol. 2021 Aug;69:247-255
pubmed: 34175654
Biol Psychiatry. 2022 Mar 1;91(5):498-507
pubmed: 34364650
Neuron. 2010 Dec 22;68(6):1067-81
pubmed: 21172610
J Neuropathol Exp Neurol. 2013 Dec;72(12):1106-25
pubmed: 24226267
J Neurotrauma. 2017 Apr 1;34(7):1364-1381
pubmed: 27784203
Int J Mol Sci. 2022 Jun 30;23(13):
pubmed: 35806324
Mol Psychiatry. 2023 Jun;28(6):2215-2227
pubmed: 36918705
J Exp Med. 2022 Mar 7;219(3):
pubmed: 35212707
J Neuroinflammation. 2023 Mar 9;20(1):67
pubmed: 36894951
Ann Neurol. 2005 Dec;58(6):920-8
pubmed: 16240366
Curr Opin Neurobiol. 2017 Dec;47:104-112
pubmed: 29065345
Proc Natl Acad Sci U S A. 1983 Oct;80(19):6126-30
pubmed: 6577472
N Engl J Med. 1998 Jan 29;338(5):278-85
pubmed: 9445407
Nat Commun. 2019 Nov 7;10(1):5067
pubmed: 31699990
Curr Gene Ther. 2014;14(5):343-51
pubmed: 25687501
Acta Neuropathol. 2017 Mar;133(3):353-366
pubmed: 27885490
J Neurosci. 2002 Nov 1;22(21):9340-51
pubmed: 12417659
Exp Neurol. 2019 Nov;321:113040
pubmed: 31445042
J Neurotrauma. 2019 Mar 1;36(5):735-755
pubmed: 30136628
J Neurotrauma. 2018 Oct 15;35(20):2357-2364
pubmed: 29774826
J Neurobiol. 2003 Feb 15;54(3):457-72
pubmed: 12532397
J Neurosci Res. 2023 Jun;101(6):843-865
pubmed: 36624699
Brain. 2020 Dec 1;143(12):3685-3698
pubmed: 33099608
J Comp Neurol. 2019 Apr 1;527(5):985-998
pubmed: 30408165
iScience. 2022 Aug 05;25(8):104832
pubmed: 35992067
Acta Neuropathol. 2021 Dec;142(6):937-950
pubmed: 34608542
J Neurotrauma. 2019 Feb 15;36(4):576-588
pubmed: 29993324
Front Neuroanat. 2015 May 28;9:70
pubmed: 26074784
Acta Neuropathol Commun. 2022 Jan 31;10(1):13
pubmed: 35101132
Neurobiol Dis. 2020 Feb;134:104683
pubmed: 31765727
Glia. 2023 Apr;71(4):1002-1017
pubmed: 36565228
Exp Neurol. 2020 Apr;326:113180
pubmed: 31930992
Proc Natl Acad Sci U S A. 2021 May 11;118(19):
pubmed: 33941692
Brain. 2022 Jun 30;145(6):2064-2076
pubmed: 35377407
Curr Opin Neurobiol. 2020 Aug;63:59-66
pubmed: 32311648
Acta Neuropathol Commun. 2023 Mar 31;11(1):56
pubmed: 37004127
Curr Opin Neurobiol. 2023 Jun;80:102722
pubmed: 37028201
J Neurotrauma. 2018 Jul 23;:
pubmed: 29690824
Glia. 1995 Oct;15(2):141-51
pubmed: 8567065
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E11029-E11036
pubmed: 29203673
J Neurosci. 2016 Sep 14;36(37):9647-58
pubmed: 27629715
J Neurotrauma. 2020 Jan 1;37(1):80-92
pubmed: 31317824
Ann Neurol. 2014 Feb;75(2):241-54
pubmed: 24243523
Brain Inj. 2022 Apr 16;36(5):620-627
pubmed: 35125061
Acta Neuropathol Commun. 2021 May 17;9(1):89
pubmed: 34001261
Exp Neurol. 2020 Jul;329:113310
pubmed: 32289316
Int J Mol Sci. 2021 Jan 18;22(2):
pubmed: 33477535
J Neuroimmunol. 2019 Jul 15;332:112-125
pubmed: 31005712
J Neurotrauma. 2023 Mar;40(5-6):482-492
pubmed: 36170576
J Neurotrauma. 2023 Jun;40(11-12):1144-1163
pubmed: 36576018
Trends Neurosci. 2022 Apr;45(4):272-283
pubmed: 35153084
Int J Mol Sci. 2020 Jul 16;21(14):
pubmed: 32708732
Neuroradiol J. 2022 Aug;35(4):468-476
pubmed: 34643120
Brain Res Bull. 1984 Jun;12(6):657-68
pubmed: 6206929
Mult Scler. 2013 Feb;19(2):153-61
pubmed: 22723571
Nature. 2022 Nov;611(7937):769-779
pubmed: 36385529
Alzheimers Dement. 2023 Jul;19(7):3065-3077
pubmed: 36696255
Acta Neuropathol. 2021 Aug;142(2):295-321
pubmed: 34019156
Proc Natl Acad Sci U S A. 2020 Nov 17;117(46):29069-29079
pubmed: 33139536
J Neurosci. 2018 Oct 10;38(41):8723-8736
pubmed: 30143572
Am J Pathol. 2008 Jan;172(1):123-31
pubmed: 18079436
Sci Transl Med. 2021 Sep 29;13(613):eabg9922
pubmed: 34586833
Neurology. 2018 Oct 9;91(15):e1385-e1389
pubmed: 30209234
Brain. 1947 Jun;70(Pt 2):179-222
pubmed: 20261820
J Neurobiol. 1998 Nov 15;37(3):413-28
pubmed: 9828047
Front Aging Neurosci. 2023 Feb 10;15:1096206
pubmed: 36845656
Brain. 2013 Jan;136(Pt 1):28-42
pubmed: 23365092
J Alzheimers Dis. 2023;91(1):225-232
pubmed: 36373318
Neuron. 2007 Feb 1;53(3):337-51
pubmed: 17270732
Prog Neurobiol. 2022 Oct;217:102332
pubmed: 35870679
J Neuropathol Exp Neurol. 2015 Mar;74(3):218-32
pubmed: 25668562
Neuron. 2000 Oct;28(1):41-51
pubmed: 11086982
Sci Transl Med. 2012 May 16;4(134):134ra60
pubmed: 22593173
Acta Neuropathol Commun. 2022 May 2;10(1):67
pubmed: 35501931
Ann Neurol. 2023 Jan;93(1):164-174
pubmed: 36214568
Nature. 2021 Oct;598(7879):188-194
pubmed: 34616074
Front Neurol. 2013 Aug 13;4:114
pubmed: 23964266
Neurology. 2020 Jan 21;94(3):e232-e240
pubmed: 31871218
Mol Cell Neurosci. 2015 May;66(Pt B):81-90
pubmed: 25758552
J Neurochem. 2003 Aug;86(3):582-90
pubmed: 12859672
Annu Rev Pathol. 2019 Jan 24;14:239-261
pubmed: 30355155
Acta Neuropathol. 2022 Nov;144(5):967-985
pubmed: 36107227